MAIN MENU

BACK

BACK

  • Home

  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • Partners
  • Client Login
Explore PAREXEL
  • JourneyGO
  • SolutionsGO
  • ExperienceGO
  • Outsourcing ModelsGO
  • Planning
  • Phase I
  • Phase IIa
  • Phase II-III
  • Phase IIIb-IV
  • Post Launch
  • Clinical Research
    • Early Phase Services
      • Dedicated Therapeutic Expertise
        • Early Phase and Late Phase integrated study management
      • Patient Populations
      • Strategic Locations
        • Berlin
          • Virtual Tour
        • London
          • Virtual Tour
        • Baltimore
          • Facility
          • Virtual Tour
        • Los Angeles
          • Virtual Tour
        • Bloemfontein
          • Facility
          • Virtual Tour
      • Phase 1, First in Human
        • Ethnobridging for Accelerated Global Drug Development
      • Phase IIa, Proof of Concept
      • Early Product Development
      • Ethnobridging
      • Clinical PK/PD and Pharmacometrics Services
        • Case Study: Safety/Pharmacovigilance #1
        • Case Study: Safety/Pharmacovigilance #2
      • Bioanalytical and Biomarkers
      • Bioequivalence Studies
      • Volunteer to Participate
    • Phase II-III Services
      • Phase III
        • Case Study: Chronic Renal Failure
        • Case Study: Expanded Access Program
        • Case Study: Accelerating development in global COPD trials
      • Medical Writing and Submission
      • Feasibility and Enrollment
        • Patient Recruitment
          • Case Study: Pediatric Migraine Patient Recruitment
        • Country and Site Selection
        • Alliance Site Strategy
        • Protocol Optimization
    • Phase IIIb-IV
    • ForeSite™ Clinical Trial Methodology
      • Study Design
      • Study Start-Up
      • Study Execution
    • Quantitative Clinical Development Services
    • Biostatistics Services
    • Clinical Trial Supplies & Logistics
      • Global Reach
      • Clinical Trial Supplies
      • Ancillary Supplies
      • Laboratory Logistics Services
      • Randomization and Trial Supply Management
      • Cold Chain Logistics
      • Clinical Trial Supply Chain - Active Tracking
    • Customer Care Services
    • Genomic Medicine Services
    • Clinical Adjudication Services
  • Informatics
    • Study Management and Monitoring
      • IMPACT® CTMS Software
      • IMPACT® CTMS Support
      • IMPACT® Progress
      • IMPACT® MySites
      • IMPACT® Investigator
      • IMPACT® Payments
      • IMPACT® Clinical Supplies Tracking
      • Data-Driven Monitoring
        • Clinical Leader Interview with Camie Briton
      • Combined EDC-RTSM
      • Integration Services
      • MyTrials® Analytics
    • Electronic Data Capture
      • DataLabs® EDC
        • EDC ranked highest in customer satisfaction
        • Taking the Pain out of EDC Deployment
      • DataLabs® EDC Training
    • Randomization and Trial Supply Management
      • ClinPhone® RTSM for Early Phase
      • ClinPhone® RTSM for Phase II/III
        • Faster implementation of RTSM (a.k.a. IRT) systems
        • Drug Accountability
        • Reporting Solutions
      • ClinPhone® RTSM for Peri/Post-Approval
      • ClinPhone® RTSM for Asia-Pacific
      • Clinical Trial Supplies & Logistics
      • Clinical Trial Supply Chain - Active Tracking
      • ClinPhone RTSM Mobile App
    • Medical Imaging
      • Therapeutic Expertise
        • Oncology Imaging Expertise
          • Criteria Experience
            • 1996 NCI-WG CLL
            • IWCLL 2008
              • Key Topics: IWCLL 2008
                • Definitions
                • Usable Criteria to Evaluate
                • Target Sites of Disease
                • Non-Target Sites of Disease
                • Organomegaly
                • New Lesions
                • B symptoms
                • Blood Counts
                • Bone Marrow
                • Transformation
                • Role of Imaging in CLL Clinical Trials
                • Clinical Data Assessments
            • 1999 IWG-NHL
            • 2007 IWG-NHL
              • Key Topics: 2007 IWG-NHL Assessment Criteria
                • Definitions
                • Usable Criteria to Evaluate
                • Target Sites of Disease
                • Non-Target Sites of Disease
                • Organomegaly
                • New Lesions
                • Bone Marrow
                • Other Laboratory Values and Symptoms
                • Incorporation of FDG-PET
                • Defining Normal, Abnormal and Measurable
                • Problem with CRu
            • RECIST
        • Respiratory and Pulmonology Imaging Expertise
        • Ophthalmology Imaging Expertise
        • Gastroenterology Imaging Expertise
        • Dermatology Imaging Expertise
        • Women's Health Imaging Expertise
        • Musculoskeletal (MSK) Imaging Expertise
        • Neurology Imaging Expertise
        • Volumetric Imaging Expertise
        • Cardiovascular Imaging Expertise
      • Imaging Services
      • Scientific Advisors
      • Consultation
      • Advanced Medical Imaging
        • Cloud-Based Solutions for Sites
    • Patient Sensors
    • Regulatory Information Management
      • LIQUENT InSight®
      • Regulatory Cloud
      • Regulatory Outsourcing Services
    • Customer Care Services
    • PAREXEL's Education Services
      • IMPACT® CTMS Training
      • LIQUENT® InSight Training
        • Courses & Registration
          • LIQUENT InSight® for Submission Management
            • LIQUENT InSight®Submission Planning and Tracking
          • LIQUENT SmartDesk™
            • Automating the Publishing Process with LIQUENT SmartDesk™ for PDF
          • LIQUENT InSight for Viewing
            • Reviewing Submissions with LIQUENT InSight® for Viewing
        • Training Resources
      • DataLabs® EDC Training
      • Perceptive MyTrials® Training
      • Data-Driven Monitoring Training
      • Certification Programs
      • Other Training Services
    • Electronic Clinical Outcome Assessments (eCOA)
      • ePRO (electronic Patient Reported Outcomes)
      • Clinical Outcome Assessments Consulting
    • Asset Transfer Services
  • Consulting
    • Integrated Product Development
      • A Biosimilar Milestone with Implications
    • Regulatory Compliance & Risk Management
      • Q&A about GCP
        • Quality By Design Putting Theory Into Practice
      • Strategic Compliance: Data Integrity
      • FDA 483s: Your Questions Answered
      • Important Reminder About PET (Positron Emitting Topography) FDA Regulations
      • Quality By Design Putting Theory Into Practice
    • Regulatory Outsourcing Services
      • eCTD
    • Regulatory Information Management & IDMP Solutions
      • IDMP Readiness Assessment
      • IDMP Task Force Updates
        • November 2015 Task Force Meeting
    • Market Access Consulting
  • Access
    • Real World Evidence
      • Late-Stage Clinical Operations
        • Late Phase Interventional Trials
        • Observational Research
        • Epidemiology
        • Expanded Access Programs
        • Clinical Outcome Assessment (COA)
          • Case Study: Health Economics
          • Outcomes Research
      • Real World Data Services
    • Drug Safety Services
      • Risk Management / REMS
    • Market Access Consulting
      • Commercial Decision Pathways
      • Evidence Generation
        • Evidence Review and Meta-Analysis
          • Evidence Review Options
          • Evidence Review Resources
        • Health Economic Modeling
        • Global and AMCP Value Dossiers
        • Manuscripts and Posters
        • Data Analytics
        • Strategic Communications
      • Access Realization
        • Pricing, Reimbursement and Market Access Expertise
        • List of Services: Pricing, Reimbursement and Market Access
      • Market Access and HUB Services
    • Medical Communications
      • Communication Strategy
      • Publications Planning and Scientific Content
      • Expert Identification and Engagement
      • Global Study Engagement
      • Branding and Creative Strategy
      • Digital Media and Video Solutions
      • Live and Virtual Events
      • Payer Communication
      • Editorial and Production
  • Therapeutic Expertise
    • Oncology
    • Cardiovascular & Metabolic Diseases
    • Central Nervous System (CNS) Disorders
    • Infectious Disease
    • Respiratory Capabilities
    • Rheumatology & Immunology Capabilities
    • Rare Diseases
  • Industry Expertise
    • Pharmaceuticals
      • Biosimilar Consulting
    • Medical Devices
    • Biologics
    • Biosimilars
      • Biosimilar Video
  • Regulatory Expertise
  • Market Access Expertise
  • Global Presence
    • North America
    • South America
    • Europe
    • Asia
    • Middle East & Africa
    • Emerging Markets
  • Strategic Partnerships
  • ExecuPharm Functional Service Solutions
  • PAREXEL® BioPharm Unit
  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • Partners
  • Client Login
  • Journey
    • Planning
    • Phase I
    • Phase IIa
    • Phase II-III
    • Phase IIIb-IV
    • Post Launch
  • Solutions
    • Clinical Research
      • Early Phase Services
      • Phase II-III Services
      • Phase IIIb-IV
      • ForeSite™ Clinical Trial Methodology
      • Quantitative Clinical Development Services
      • Biostatistics Services
      • Clinical Trial Supplies & Logistics
      • Customer Care Services
      • Genomic Medicine Services
      • Clinical Adjudication Services
    • Informatics
      • Study Management and Monitoring
      • Electronic Data Capture
      • Randomization and Trial Supply Management
      • Medical Imaging
      • Patient Sensors
      • Regulatory Information Management
      • Customer Care Services
      • PAREXEL's Education Services
      • Electronic Clinical Outcome Assessments (eCOA)
      • Asset Transfer Services
    • Consulting
      • Integrated Product Development
      • Regulatory Compliance & Risk Management
      • Regulatory Outsourcing Services
      • Regulatory Information Management & IDMP Solutions
      • Market Access Consulting
    • Access
      • Real World Evidence
      • Drug Safety Services
      • Market Access Consulting
      • Medical Communications
  • Experience
    • Therapeutic Expertise
      • Oncology
      • Cardiovascular & Metabolic Diseases
      • Central Nervous System (CNS) Disorders
      • Infectious Disease
      • Respiratory Capabilities
      • Rheumatology & Immunology Capabilities
      • Rare Diseases
    • Industry Expertise
      • Pharmaceuticals
      • Medical Devices
      • Biologics
      • Biosimilars
    • Regulatory Expertise
    • Market Access Expertise
    • Global Presence
      • North America
      • South America
      • Europe
      • Asia
      • Middle East & Africa
      • Emerging Markets
  • Outsourcing Models
    • Strategic Partnerships
    • ExecuPharm Functional Service Solutions
    • PAREXEL® BioPharm Unit
  • Company
    • Management Team
      • Josef H. von Rickenbach
      • Mark A. Goldberg, M.D.
      • Roland Andersson, Ph.D.
      • Christian Dreger. Ph.D.
      • Xavier Flinois
      • David J. Godwin
      • Michelle Graham
      • Simon Harford
      • Sy Pretorius, M.D.
      • Gadi Saarony
      • Joshua Schultz
    • News & Events
      • Press Releases
      • Events
      • Webinars
      • 12th Annual Partnerships in Clinical Trials Congress
      • Archived PAREXEL in the News
    • Find an Office
    • Careers
      • Careers at PAREXEL®
      • CEO Message
      • Find Your Path - Opportunities
      • University Graduates – Opportunities for students
    • Volunteer
      • About Us
      • Locations Worldwide
      • About Clinical Trials
      • Why Participate?
      • FAQs
      • Glossary
    • Sustainability
      • Consumption Trend Analysis
    • Code of Conduct
    • eClinical Innovation
    • Purchasing
      • Purchase Order Terms and Conditions
      • Bedingungen für den Kaufauftrag
      • Vigente desde el
      • PO Terms - Japanese
      • PO Terms - Chinese 'S'
      • PO Terms - Chinese 'T'
      • Ordem de Compra Termos e Condições
    • Contact Us
      • Thank You
    • Partners
      • Service Partners
      • Training Partners
      • Technology Partners
      • Referral Partners
      • Accredited Partner Program
  • Perceptive®
  • User Group Meeting
    • IMPACT CTMS User Group Meeting Details and Agendas
    • IMPACT CTMS User Group Meeting Justification Letter
    • Meeting Registration and Hotel Details
    • Benefits for attending the IMPACT CTMS User Group Meeting
    • Registration Rates
    • Hotel Rates
  • Horizons
    • About
    • Locations
    • FAQs
    • Agenda
    • Submit Abstract
  • Graduate
    • High Performance Culture
    • Graduate Content Template Test
    • GRAD TEST
    • Career Profiles Overview
      • Career Profile Meghan
      • Career Profile Adam
    • Great Place to Work
  • parexel-insights
    • HOW TO EFFECTIVELY DEVELOP CLINICAL DOCUMENTS IN THE EU/US AND CHINA NDA DOSSIER
    • Improving Site Experience with Risk-Based Monitoring
    • Immuno-Oncology: Past, Present and Future
    • High Performance Workplace Practices That Attract and Retain Millennials
    • Increasing Study Predictability
    • Mergers & Acquisitions: Where’s the Real Finish Line?
    • Navigating Regulatory Submissions
    • Interview with PAREXEL’s Aida Sabo, About Challenges & Successes in Diversity & Inclusion
    • Utilizing Secondary Healthcare Data Assets
    • Optimizing the clinical development process with Social, Mobile, Analytics, and Cloud (SMAC)
    • Training Compliance is an Increasingly Complex Journey
    • Beyond Diversity: What Happens When You Define a Culture of Inclusion
    • The Next Generation of Talent Management: Opportunities For Diversity
    • Get Into Pole Position with Modern IRT Services
    • When It Comes to CTMS One Size Does Not Fit All
    • Protocol Optimization
    • Using Analytics to Optimize The Clinical Development Process
    • Shogo Nakamori Discusses Joint Program for Clinical Research
    • Josh Schultz, Corp. VP Talks About PAREXEL Access
    • New Approaches to Data Management in Clinical Trials
    • Shogo Nakamori Discusses Japan & Multi-national Trials
    • Shogo Nakamori Discusses Trends in Drug Development in Japan
    • Involved & Engaged: The Last Mile of Business Performance
    • Why RTSM & IRT stand for Speed, Simplicity & Service
    • Dream or Reality- Improving Patient Safety & Reducing Costs?
    • Drew Garty Discusses Data Driven Monitoring
    • Albert Liou Discusses the Drug Development Landscape in Korea
    • Roland Andersson, SVP, Discusses Investing Trends and Emerging Biopharmaceutical Companies
    • Mark A. Goldberg, President & COO, Discusses PAREXEL’s Acquisition of Quantum Solutions India (QSI)
    • Albert Siu, PhD, Explains How PAREXEL Academy Benefits Clients
    • Ubavka DeNoble Talks About PAREXEL's BioPharm Unit
    • Dr. Sy Pretorius, Chief Scientific Officer Talks About Adaptive Design Trials
    • PAREXEL’s Training Approach and the Importance of Training a Global Workforce
    • Clinical Trial Support Query - Who Ya Gonna Call?
    • Clinical Trial Feasibility & Patient Enrollment: Differentiation Through Innovation
    • Innovation in the Pharmaceutical Industry: A Change Toward Personalized Medicine
    • A Biosimilar Milestone with Implications
    • Designing Trials Payers Can Trust
    • The Human Touch: Aligning Reward Systems with Company Strategy and Meaningful Work
    • Diversity and Inclusion: This Is How the Best Global Companies Learn, Plan, and Measure Success
    • Accelerated Pathways and Stock Prices
    • Accelerated Pathways & Commercial Consequences Forum & Findings
    • Accelerated Pathways: Global Opportunities & Challenges for Innovators
    • 'Now is the time to include Japan' says PAREXEL
    • A People Strategy Attracts the Best Talent
    • Three Keys To Mitigating Risk In Adaptive Trials
    • How to Know You’re Keeping Your (Clinical Trial Supplies) Cool
    • Adaptive Trials: Complex But Advantageous
    • Best Practices to Improve the IRT Site User Experience
    • Anything is Possible
    • If You Never Stop Learning, You Can Never Stop Earning
    • Clarifying the Criteria that Better Capture Antitumor Activity of Immune Therapeutics
    • 30 Years Later: Lessons from Living in a Pandemic
    • The Complete Journey: Improving Clinical Trials Using Modern Technology
    • Demonstrating Value and Managing Risk Throughout Development
    • The Clinical, Regulatory and Commercial Implications of Rapid Approval
    • 3 Principles for a Sound Clinical and Regulatory Document Strategy for Small Biopharmaceuticals
    • The Collaborative Advantage of Biopharma Companies and Global Service Providers
    • Successfully Integrating Electronic Health Record and Electronic Data Collection Data
    • The Emerging Role of Wearable Devices For Real-World Data Collection
    • Grateful for Advancements in Medicine
    • Focused on the Finish Line
    • Running with a Purpose
    • Rooting for Team Jessie
    • Working Towards a Glimpse of a Cure
    • Something Good Always Comes From Something Bad
    • The Journey Continues – I Got This
    • When the Doctor Becomes the Patient
    • Recognizing Uncle David
    • Life is Short and Love is Eternal
    • Dragons - the Guardians of Disease
    • "Yes, I Can!"
    • This Disease Will Not Win the Fight
    • Attitude is Everything
    • Surveillance or Surgery?
    • Active Tracking Is Out To Reduce Sites’ Workload
    • Want Your Business to Thrive? Focus on Developing Your People
    • Quantitative Modeling For Clinical Trials
    • Genomic Medicine, Data Modeling and Clinical Trials
    • How Protocol Optimization Improves Clinical Trial Outcomes
    • Three Skills Developers Will Need to Thrive in the New Era of Genomic Medicine
    • Clinical Development of Next Generation Biologics
    • Trends in Translational Development
    • On Demand Webinar - The Power of Foresight: Improving Drug Development Performance through Optimized Protocol Design
    • Effective Late Stage Pathways For Biosimilar Products
    • Navigating Regulatory Complexities Of Biosimilar Development
    • Contracting - A Key Component Of A Strong Vendor Relationship
    • Imaging Endpoint Selection For Biosimilar Development
    • How to Simplify Site Tasks and Help Ensure Dispensing Accuracy
    • Medical Writing for Submission to Asia-Pacific Regulatory Authorities
    • Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development
    • How to Maximize Potential and Sidestep Pitfalls of MAPs
    • Developing Drugs in the New Era of Personalized Medicines
    • How Performance Reviews Support High-Performance Talent
    • How do eClincal solutions Increase Clinical Trial Efficiency?
    • So, My Fitbit is Clinical Trial Grade Right?
    • Orphan Drug Pricing in Europe
    • Wearables Shaping the Future of Clinical Trials
    • PAREXEL's Connected Journey™ of Data-Driven Services
    • Overcoming Data Capture and Management Challenges
    • Driving the Digital Transformation of the Industry
    • The Evolution of Drug Development & Market Access via Connected Data-driven Solutions
    • CONSIDERATIONS IN BIOSIMILARS DEVELOPMENT– A US FDA PERSPECTIVE
    • WHAT CAN WE LEARN FROM IMMUNO-ONCOLOGY CLINICAL TRIALS?
  • agile-IRT
    • Agile IRT
    • Reduced Timelines
    • Simpler Processes
    • Expert Services
    • Contact
  • test
  • Menu
Home

THE CONNECTED JOURNEY™ OF DATA-DRIVEN SERVICES

Watch the video

Read Brochure


Inside PAREXEL:

The Connected Journey™ of Data-Driven Services

Data-Driven Insights

See how our commitment to informing our client conversations with the best possible insights, leads to better decisions that simplify the journey. WATCH VIDEO


Inside PAREXEL:

The Connected Journey™ of Data-Driven Services

Real World Data Services

Today, real world data is critical at every step of the journey to market, and our clients count on us to help analyze the right data to uncover the most valuable insights. WATCH VIDEO


Inside PAREXEL:

The Connected Journey™ of Data-Driven Services

Analytics and Technology

Industry-wide change is happening. See how we’re leading the way with PAREXEL® Analytics, our integrated technology platform. WATCH VIDEO

 
 

Journey

Solutions

Experience

Outsourcing Models

  • Journey
  • Solutions
  • Experience
  • Outsourcing Models
Explore More
X

The first steps of any journey include choosing the smartest route to your destination. To do that well, start by choosing the industry leadership and global resources of PAREXEL.

- Explore Planning
Explore More
X

To simplify your journey from new molecules to new medications, start with a partner who’ll be beside you at every step with expertise, technologies, and facilities worldwide.

- Explore Phase I
Journey1
Explore More
X

By accelerating your access to the right patients and expertise for your journey, we accelerate your access to the efficacy data you need to persuade key stakeholders.

- Explore Phase IIa
Explore More
X

While our strategic expertise, global resources, and clinical logistics speed pivotal trials, our eClinical technologies and regulatory insights cut your costs, risks, and delays.

- Explore Phase II-III
Explore More
X

As you approach your NDA submissions, having a technologically advanced, integrated late phase team with global and local insight to steer you through is crucial.

- Explore Phase IIIb-IV
Explore More
X

After all the science, trials, and paperwork, how far your new drug will go depends on its use in the real world. PAREXEL's world class post-launch team can take your further.

- Explore Post Launch
Explore More
X

Partner with PAREXEL throughout your journey for more clinical expertise, regulatory insights, dedicated trial sites, and quality patients. All with less cost and fewer delays.

- Explore Clinical Research
Explore More
X

PAREXEL's advanced, integrated eClinical and regulatory technology platforms expedite your journey, improve data tracking, and cut costs at every phase, end-to-end.

- Explore Informatics
Explore More
X

Your new drug's journey to market will go more smoothly with PAREXEL's mastery of efficacy results, regulations, reimbursement, and market access beside you.

- Explore Consulting
Explore More
X

A unique, simplified and complete solution that can help identify, generate, evaluate and communicate the evidence of product value.

- Explore Access
Explore More
X

You create your new discovery to treat today's worst medical conditions. PAREXEL has the oncology, CNS, cardiovascular, respiratory, and other medical expertise you need in a partner.

- Explore Therapeutic Expertise
Explore More
X

PAREXEL has some of the most experienced, most talented minds worldwide finding solutions to keep our biopharmaceuticals and medical device clients on course from beginning to end.

- Explore Industry Expertise
Explore More
X

A global footprint is common in today’s biopharmaceuticals industry. But PAREXEL has 77 locations in 51 countries, all interconnected in real time and harmonized to the same SOPs.

- Explore Global Presence
Explore More
X

Your path to a successful new drug will hit many regulatory hurdles. Our top regulatory experts and technologies optimize trial data, ease filings, and keep you moving ahead.

- Explore Regulatory Expertise
Explore More
X

Let PAREXEL's commercialization experts analyze market potential, health sector impacts, payer coverages, and more to secure crucial first market access for your new drug.

- Explore Commercialization Expertise
Explore More
X

The PAREXEL® BioPharm Unit delivers innovative solutions to help small to mid-sized companies expand their in-house expertise, support internal decision-making and position themselves among industry leaders.

- Explore the PAREXEL® BioPharm Unit
Explore More
X

ExecuPharm Functional Service Solutions supplies a full-range of functional resources, management, processes and easy to use tracking systems for any clinical study.

- Explore Functional Services
Explore More
X

PAREXEL’s Strategic Partnerships are a more collaborative and operationally efficient relationship allowing you to reach your drug development milestones faster and smarter.

- Explore Strategic Partnerships
  • Video Highlights
  • PAREXEL Insights
  • News & Events
  • Highlights
Simplifying Clinical Trial Design and Execution
with PAREXEL®
Inside PAREXEL:
Predictive Modeling
Inside PAREXEL:
Genomic Medicine
Inside PAREXEL:
Protocol Optimization
Utilizing Secondary Data Assets
PAREXEL® Access
Navigating Regulatory Submissions
PAREXEL® Consulting
Increasing Study Predictability
PAREXEL® Clinical Development Optimization
Nothing is Bigger than Your Molecule
PAREXEL® Clinical Research Services
Beginning with the End in Mind
PAREXEL® Clinical, Regulatory and Commercial Consulting
Using Technology to Bring it All Together
PAREXEL® Clinical Trials Technology
PAREXEL's Alberto Grignolo, PhD
Comments on Key Trends at DIA 2015
CONCEPT TO COMMERCIALIZATION
Solving the Complex
PATENT TO PATIENT
The Bigger Journey: Navigating the Human Pathway
GLOBAL FOOTPRINT TO GLOBAL MIND
Capitalizing on Intellectual Capital
More Videos

PAREXEL Expert Discusses Rapid Evolution of Japanese Clinical Research Environment

Read more

PAREXEL Experts Discuss Trial Design in MedCityNews

Read more

PAREXEL Experts Discuss The Power of Data Standardization

Read more
October 26, 2017

PAREXEL Enhances Its Active Tracking Service with Bluetooth Capability to Improve Monitoring of Temperature-Controlled Medication

October 24, 2017

PAREXEL and Microsoft Form Cloud Technology Alliance Aimed at Accelerating the Pace of Drug Development

September 29, 2017

Pamplona Capital Management Completes Acquisition of PAREXEL International

Browse by Topic

  • BioPharm Business Trends
  • Data Analytics and Insights
  • Global Drug Development
  • Regulatory and Market Access
  • Talent Management
  • Technology Solutions
  • Workplace and Culture

View All PAREXEL Insights

Latest Insights

WHAT CAN WE LEARN FROM IMMUNO-ONCOLOGY CLINICAL TRIALS?

by PAREXEL International

In this article, What Can We Learn From Immuno-oncology Clinical Trials?, the clinical trial…

CONSIDERATIONS IN BIOSIMILARS DEVELOPMENT– A US FDA PERSPECTIVE

by Dr. Partha Roy

In this article, learn the key US specific concepts for clinical development programs as well as the…

The Evolution of Drug Development & Market Access via Connected Data-driven Solutions

by PAREXEL International

The Connected Journey™ of data-driven services in action! Read the case studies and learn about…

  • Video Highlights
  • X close
    Simplifying Clinical Trial Design and Execution
    with PAREXEL®
    Inside PAREXEL:
    Predictive Modeling
    Inside PAREXEL:
    Genomic Medicine
    Inside PAREXEL:
    Protocol Optimization
    Utilizing Secondary Data Assets
    PAREXEL® Access
    Navigating Regulatory Submissions
    PAREXEL® Consulting
    Increasing Study Predictability
    PAREXEL® Clinical Development Optimization
    Nothing is Bigger than Your Molecule
    PAREXEL® Clinical Research Services
    Beginning with the End in Mind
    PAREXEL® Clinical, Regulatory and Commercial Consulting
    Using Technology to Bring it All Together
    PAREXEL® Clinical Trials Technology
    PAREXEL's Alberto Grignolo, PhD
    Comments on Key Trends at DIA 2015
    CONCEPT TO COMMERCIALIZATION
    Solving the Complex
    PATENT TO PATIENT
    The Bigger Journey: Navigating the Human Pathway
    GLOBAL FOOTPRINT TO GLOBAL MIND
    Capitalizing on Intellectual Capital
    More Videos
  • PAREXEL Insights
  • WHAT CAN WE LEARN FROM IMMUNO-ONCOLOGY CLINICAL TRIALS?

    by PAREXEL International

    In this article, What Can We Learn From Immuno-oncology Clinical Trials?, the clinical trial…

    CONSIDERATIONS IN BIOSIMILARS DEVELOPMENT– A US FDA PERSPECTIVE

    by Dr. Partha Roy

    In this article, learn the key US specific concepts for clinical development programs as well as the…

    The Evolution of Drug Development & Market Access via Connected Data-driven Solutions

    by PAREXEL International

    The Connected Journey™ of data-driven services in action! Read the case studies and learn about…

    View All PAREXEL Insights

  • News & Events
  • October 26, 2017

    PAREXEL Enhances Its Active Tracking Service with Bluetooth Capability to Improve Monitoring of Temperature-Controlled Medication

    October 24, 2017

    PAREXEL and Microsoft Form Cloud Technology Alliance Aimed at Accelerating the Pace of Drug Development

    September 29, 2017

    Pamplona Capital Management Completes Acquisition of PAREXEL International

  • Highlights
  • PAREXEL Expert Discusses Rapid Evolution of Japanese Clinical Research Environment

    Read more

    PAREXEL Experts Discuss Trial Design in MedCityNews

    Read more

    PAREXEL Experts Discuss The Power of Data Standardization

    Read more

Linkedin Updates

View Profile
  • #ICYMI: @PAREXEL & @Sanofi join to collect crucial #data on #wearables in #clinicaltrials. https://t.co/4jyqX4TY4a… https://t.co/qNZFuV9K1g
  • ICYMI: @PAREXEL's Colette Thorold discusses the importance of #coldchain management in #clinicalresearch… https://t.co/WbRvQrzBfc
  • Don't miss @PAREXEL's Monica Kobayashi during #ISPORGlasgow - Nov. 8! Check out this study she co-authored:… https://t.co/At9uXY1n9d

CAREERS AT PAREXEL®

If you are inspired to make a difference
in the world, we can help you make it possible.

Search positions worldwide

PAREXEL International Corp.
+1 781 487 9900
195 West Street
Waltham, MA 02451 

  • ABOUT PAREXEL®
  • NEWS & EVENTS
  • VOLUNTEER
  • CONTACT
  • MY PAREXEL PREFERENCE CENTER
  • CLIENT LOGIN
  • LIQUENT®
  • CLINICAL TRIAL INVESTIGATOR
  • SITE MAP
  • TERMS OF SERVICE
  • PRIVACY POLICY
  • EU-U.S. AND SWISS-U.S. PRIVACY SHIELD NOTICE OF CERTIFICATION

Copyright ©2000-2017 PAREXEL International Corporation.